As a PI, Dr. Adrian Udrea has proven track record of professionalism, conducting over 80 successful clinical trials, a great number being conducted at Medisprof. During the past eight years, Medisprof has become a landmark as a Romanian research site and is continuing to grow thanks to our qualified research team. Being Chief Medical Officer has shown me the difficulties of leadership but also the perspective of future achievements with the proper team. As a recognition of our efforts, in August 10, 2018 we received the QOPI certification from ASCO.
Abdalla Abo Taleb is one of the most profound experts in healthcare policy and regulations in the MENA region His expertise extend from HTA & Reimbursement policies to regulatory and supply chain strategies in the public sector. He has been involved in the fields of health economics, outcomes research, Health policy reforming and reimbursement polices within the healthcare industry for 15 years, with experience across the pharmaceutical, biologicals and vaccines. And now works for WHO as a project manager at health care reforming area. He, in addition to being a committee member and project manager in a number of national projects in many countries including Germany. United Kingdom, Egypt, Algeria, Sudan, Russia, UAE, Morocco, Jordan, Iraq, Turkey, KSA, GULF, USA and Poland, He is a very active researcher with tens of publication across different well recognized organizing including ISPOR, ESMO, ASCO, ECCO, iHEA. HTAI and EuHEA. He has been a true contributor to several public and industrial projects in Egypt and MENA region his homeland. He committedly changed the landscape of the healthcare policy there .A few examples to mention are his contributions to the establishment of the NORCB (national organization for control and research of biologics), Egyptian Biosimilars guidelines the cancer and MS registry & guidelines. Establishing stroke units & guidelines , hospital based HTA and Health economic unit at ministry of health in Egypt’s different sectors. Multiple engagement efforts are well recognized in his research through introducing concepts of stakeholder engagement. He also does that by being an active member of many research organizations internationally and locally like the ISPOR and its local chapter. Abdalla Abo taleb remains a very rich source of developmental initiatives having been hands on expert across different sectors of the healthcare systems and a visionary for healthcare reform.
Dr. Parkin has been a practicing Medical Intuitive for several years. She earned her PhD in Energy Medicine through an innovative program designed by Dr. Norm Shealy and Dr. Caroline Myss. Dr. Parkin previously spent many years in nursing and holds a degree in Sociology and Psychology. She also teaches Health and Empowerment seminars worldwide and has founded the International College of Medical Intuition, Inc (2002) which has locations in Hawaii, Vancouver and NY. Dr. Parkin’s focus is reaching medical professionals such as nurses to further incorporate intuition for healing in the workplace. Her courses are practical and based on intuitive as well as scientific knowledge.
The Effects of Vibrational Frequency Measured Through Darkfield Analysis
Giulio Tarro graduated from Medicine School, Naples University (1962), Italy. Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus (2006). Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President, Foundation de Beaumont Bonelli for Cancer Research. His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.
Antigens induced early during the replication cycle of human herpesviruses.
Jens received his PhD in biochemistry from the Albert-Ludwigs-University Freiburg i.Br. (Germany). During several postdoc positions [Department of Molecular Pathology at the University of Bonn (Germany), Charite Berlin (Germany), Department of Gynaecology and Obstetrics at the University of Wuerzburg (Germany)] he received a broad training and knowledge in molecular pathology and cancer research. At the moment he is working in the Department of Molecular Pathology at the ICR (London, UK). He has published more than 70 papers in reputed journals and has been serving as an editorial board member of repute.
Doctor Dominique Belpomme is presently an emeritus board-certified full professor in medical oncology at the Paris University; and the executive director of the European Cancer and Environment Research Institute (ECERI), in Brussels (Belgium). After his internship in the Paris University Hospitals, Pr Belpomme joined the Pr. G. Mathé’s research team at Institute of Cancerology and ImmunoGenetics (ICIG) in Villejuif (France); then the Pr. GE Moore’s research group at Roswell Park Memorial Institute (RMPI) in Buffalo NY (USA); before he obtained his master’s degree in science and his MD degree at Paris University. Having been a full board-certified professor of medical oncology at the European Hospital Georges Pompidou (HEGP) in Paris, Pr. Belpomme has contributed greatly to therapeutic research in cancer, and to the biology of environmental carcinogenesis, through several hundred of internationally recognized peer-reviewed scientific papers, and is presently one of the European scientific leaders who contributed to organize and promote cancer research.
He is the Founder and Chief Executive Officer of Nexus Exchange Limited – an innovative century 21 youth social enterprise company, headquartered in Preston Lancashire United Kingdom, that is committed to nurturing young people and building a sustainable eco-system for young entrepreneurs and young employees all around the world. Nexus Exchange seeks to co-found more young social enterprises around the framework of the United Nations Sustainable Development Goals, that will provide innovative home grown solutions to regional and local problems. He is leading the global youth work space in the area of innovative volunteerism, a creative concept that allows young people to contribute effectively to the global work space whilst learning and honing in their skills at these companies and organisations. The Nexus Exchange youth operations currently span 5 continents and working with just under 60,000 young people from all around the world. Mr Kennedy is also the Founder & CEO of Nexus Analytica & Digital Estates Limited – an innovate digital economy consulting firm which combines ethical data mining, data brokerage and data analysis with strategic communication to provide unprecedented consumer and market data for businesses of all types and in different economic sectors.
The Role Of Social Youth Entrepreneurship In Oncology Nursing And Cancer Care